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The Absence of uPAR Is Associated with the
Progression of Dermal Fibrosis
Yosuke Kanno1, Aki Kaneiwa1, Misato Minamida1, Miho Kanno1, Kanji Tomogane1,2, Koji Takeuchi2,
Kiyotaka Okada3, Shigeru Ueshima3, Osamu Matsuo3 and Hiroyuki Matsuno1
The fibrinolytic system is considered to play an important role in the degradation of extracellular matrices
(ECM). However, the detailed mechanism regarding how this system affects fibrosis remains unclear. Urokinase-
type plasminogen activator receptor (uPAR) not only functions as a proteinase receptor but also plays a role in
cellular adhesion, differentiation, proliferation, and migration through intracellular signaling. To investigate the
effect of uPAR on dermal fibrosis, the skin of wild-type mice was compared with uPAR-deficient (uPAR/) mice.
The results showed that the absence of uPAR increases dermal thickness. In addition, collagen synthesis as well
as the number of myofibroblasts was greater in the skin of uPAR/ mice than in the skin of uPARþ /þ mice.
Moreover, we showed that the absence of uPAR attenuates the activity of matrix metalloproteinases (MMP)-2, 9
in the skin. In conclusion, this study suggests that the absence of uPAR not only regulates fibrosis-related gene
expression and MMP activity but also results in ECM deposition. Therefore, the absence of uPAR induces
dermal fibrosis. These findings provide new insights into the role of uPAR on dermal fibrosis.
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INTRODUCTION
Systemic sclerosis (SSc; scleroderma) is characterized by
excessive fibrosis of the skin and internal organs due to
excessive accumulation of extracellular matrix (ECM). The
mechanisms resulting in fibrosis in SSc are still unknown.
Fibrotic changes lead to destruction of normal histologic
structures in the skin and other organs. There are still no
effective treatments to prevent or halt the progression of
fibrosis in SSc and other fibrotic diseases (Highland and
Silver, 2005).
The fibrinolytic system contains plasminogen, a proen-
zyme, that is converted into the active serine protease
plasmin, a main component of the fibrinolytic system,
through the action of a tissue-type plasminogen activator or
urokinase-type PA (uPA)/uPA receptor (uPAR). The fibrino-
lytic system is considered to play an important role in the
degradation of extracellular matrices (ECM). However, the
detailed mechanism of how this system affects fibrosis
remains unclear.
uPAR is a glycosylated 50–60 kDa protein that
concentrates serin protease activity in the pericellular
region (Mondino et al., 1999). Recent studies indicate
that uPAR not only functions in cell surface uPA
activity and plasmin generation but also plays a role in
cellular adhesion, differentiation, proliferation, and migration
through intracellular signaling (Blasi and Carmeliet,
2002). Moreover, uPAR involves in SSc and other fibrotic
diseases (Zhang et al., 2003; D’Alessio et al., 2004; Margheri
et al., 2006).
This study was performed to assess the role of
uPAR in the development of dermal fibrosis. We herein
report, for the first time, the crucial role of uPAR on dermal
fibrosis.
RESULTS
The dermal surface features in uPARþ /þ mice and uPAR/
mice
The skin distension ability of uPARþ /þ mice was compared
to that of uPAR/ mice. The skin distension ability of
uPAR þ /þ mice was 1.28-fold greater than that of uPAR/
mice at the age of 18 weeks (Figure 1a). However, there was
no difference between uPARþ /þ mice and uPAR/ mice at
the age of 6 and 10 weeks. In addition, there was no
difference between the male and female mice (data not
shown). Moreover, to investigate the effect of uPAR defi-
ciency in the skin, the dermal surface features of uPARþ /þ
mice and uPAR/ mice were observed using electron micro-
scopy (Figure 1b). The wrinkles on the skin of uPAR/ mice
decreased by the progression of dermal fibrosis.
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The skin histology in uPARþ /þ mice and uPAR/ mice
A histological examination of the skin demonstrated a
considerable increase in the dermal thickness of uPAR/
mice as compared with uPARþ /þ mice (Figure 2a). A
quantitative analysis showed the dermal thickness of
uPAR/ mice to be 1.25-fold greater than that of uPARþ /þ
mice (Figure 2b). Masson’s trichrome staining revealed an
accumulation of ECM components. Figure 2c shows that the
accumulation of ECM components was greater in the skin of
uPAR/ mice than in that of uPARþ /þ mice. These data
suggest that the absence of uPAR induces the development of
dermal fibrosis.
The expression of uPAR in the skin
The expression of uPAR was examined by reverse transcription-
PCR (RT-PCR), western blot analysis, and immunohisto-
chemistry in the skin of wild-type mice at the age of 6, 10,
and 18 weeks (Figure 3a–d). The expression of uPAR in the
skin of wild-type mice increased with advancing age.
The effect of uPAR deficiency on dermal ECM deposition
To investigate the effect of uPAR deficiency on dermal
collagen deposition, the collagen content in the skin of
uPARþ /þ mice and uPAR/mice was measured using Sirius
red staining (Figure 4a). The collagen content in the skin of
uPAR/ mice was 1.82-fold greater than that in the skin of
uPARþ /þ mice. An increased accumulation of myofibro-
blasts in the dermis, which is characteristic of scleroderma, is
believed to contribute to the pathogenesis. To compare the
accumulation of myofibroblasts in the skin of uPARþ /þ mice
and uPAR/ mice, the expression of a-smooth muscle actin
(a-SMA) was examined. The number of a-SMA-positive cells
was 3.34-fold greater in the skin of uPAR/mice than that in
the skin of uPARþ /þ mice (Figure 4b and c). The expression
of fibrosis-related genes, type I collagen, type IV collagen,
plasminogen activator inhibitor (PAI)-1, matrix metallopro-
teinases (MMP)-2 and MMP-9 were examined by RT-PCR
analysis (Figure 4d). The expression of type I collagen, type IV
collagen, and PAI-1 was greater in uPAR/ mice than that in
uPARþ /þ mice. On the other hand, the expression of MMP-2
and MMP-9 in uPAR/ mice was less than that in uPARþ /þ
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Figure 1. The dermal surface features in uPARþ /þ mice and uPAR/ mice.
(a) Skin distension ability of uPARþ /þ mice and uPAR/ mice at the
age of 18 weeks (n¼ 6). Skin distension ability was measured as described in
the Materials and Methods section. The data represent the mean±SEM.
*Po0.05. (b) Electron microscopy of dermis in the skin of uPARþ /þ
mice and uPAR/ mice at the age of 18 weeks.
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Figure 2. The skin histology in uPARþ /þ mice and uPAR/ mice. (a) Paraffin-embedded sections of uPARþ /þ mice and uPAR/ mice at the age of 18 weeks
were stained with hematoxylin and eosin. Scale bar¼200 mm. (b) The dermal thickness (distance from the epidermal–dermal junction to dermal–muscle
junction) was measured in skin sections from uPARþ /þ mice and uPAR/ mice at the age of 18 weeks (n¼7). The data represent the mean±SEM. *Po0.01.
(c) Paraffin-embedded sections of uPARþ /þ mice and uPAR/ mice at the age of 18 weeks were stained with Masson’s trichrome stain. Scale bar¼200 mm.
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mice. In addition, the absence of uPAR attenuates the activity
of MMP-2 and MMP-9 (Figure 4e). The data suggest that the
absence of uPAR induces the accumulation of ECM
components.
DISCUSSION
This study demonstrated that the absence of uPAR develops
the progression of dermal fibrosis.
The initial observations showed that the absence of uPAR
decreased skin distension ability and increased dermal
thickness. The dermal surface of uPAR/ mice seems to be
tighter than that of uPARþ /þ mice. The absence of uPAR
might play an important role in the development of dermal
fibrosis.
The skin distension ability in uPAR/ mice decreased as
compared with the skin of uPARþ /þ mice at the age of 18
weeks, although there was no difference between uPARþ /þ
mice and uPAR/ mice at the age of 6 and 10 weeks. The
expression of uPAR in the skin of wild-type mice at the age of
6, 10, and 18 weeks was analyzed to investigate whether
the expression of uPAR was associated with aging in the skin.
The expression of uPAR increased with advancing age. The
hypothesis is that aging induced the expression of uPAR in
skin, where uPAR acts in a negative feedback loop. These
data suggest that the absence of uPAR might not be able to
repress the age-related progression of dermal fibrosis.
Fibrosis is characterized by the excessive accumulation of
ECM proteins (Knapp et al., 1977; Hunt, 1990). In normal
physiological tissue remodeling, a careful balance is maintained
between collagen synthesis and degradation, culminating in
a final collagen content that is similar, although not identical,
to the original tissue (Parks, 1999). The current study shows
that ECM deposition was greater in the skin of uPAR/ mice
than in that of uPARþ /þ mice. In addition, the collagen
content and the expression of type I collagen and type IV
collagen was greater in the skin of uPAR/ mice than that
in uPARþ /þ mice. The presence of myofibroblasts is
consistent with the pathology of fibrotic diseases (Sappino
et al., 1990; Ludwicka et al., 1992). Myofibroblasts are
specialized cells with high synthetic capacity for ECM
proteins (Gabbiani, 2003). The number of myofibroblasts
was greater in the skin of uPAR/ mice than in the skin of
uPARþ /þ mice. Bernstein et al. (2007) suggest that down-
regulation of uPAR is necessary for myofibroblast differentia-
tion. The absence of uPAR might induce myofibroblast
differentiation. Moreover, the expression of PAI-1 was greater
in the skin of uPAR/ mice than that in uPARþ /þ mice.
Bleomycin-induced fibrosis is more severe in transgenic mice
overexpressing PAI-1 and less so in PAI-1-deficient mice
(Eitzman et al., 1996). According to this alternative model,
the elevated PAI-1 promotes collagen deposition not by
inhibiting plasmin, but by stimulating the migration of
leukocytes and collagen-producing cells into the damaged
tissue (Loskutoff and Quigley, 2000). The protection from
fibrosis by PAI-1 deficiency is dependent on increased
proteolytic activity of the plasminogen activator system
(Hattori et al., 2000). The reduction of the plasmin activity
due to a deficiency of uPAR, also in association with an
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Figure 3. The expression of uPAR in the skin of wild-type mice. (a) uPAR gene expression in the skin of wild-type mice at the age of 6, 10, and 18 weeks
was determined by RT-PCR. (b) The expression of uPAR in skin of wild-type mice at the age of 6, 10, and 18weeks was determined by a western blot
analysis. Similar results were obtained with three additional and different skin samples. (c) Immunohistochemistry for uPAR in the skin of wild-type
mice at the age of 6, 10, and 18 weeks. Paraffin sections were stained with antibodies to uPAR as described in the Materials and Methods section. (d) The
number of uPAR-positive cells on the skin of wildtype mice at the age of 6, 10, and 18weeks was determined at four randomly selected sites from
different sections. The data represent the mean±SEM. *Po0.01. **Po0.05.
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alteration of fibrosis-related gene expression by uPAR
deficiency, might therefore attenuate the degradation of
ECM. Further investigation is thus required to clarify the
details.
Recent studies have demonstrated that in scleroderma and
other fibrotic diseases, reduced ECM turnover is a contribu-
tory factor for collagen accumulation and the development of
dermal fibrosis (Arakawa et al., 1996; Ghahary et al., 1996;
Hayashi et al., 1996). MMPs are enzymes that can degrade
most ECM proteins including collagen, which is the major
protein component of fibrotic tissue (Matrisian, 1992; Parks,
1999). Plasmin directly activates proMMP-1, proMMP-3,
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Figure 4. The effect of uPAR deficiency on dermal ECM deposition. (a) The collagen content was measured by a Sirius red stain on the skin of uPARþ /þ mice
and uPAR/ mice at the age of 18 weeks (n¼ 5). Sirius red-positive area was expressed as a percent of the observed in uPARþ /þ mice. The data represent the
mean±SEM. *Po0.01. (b) Immunohistochemistry for a-smooth muscle actin (a-SMA)-positive cells on the skin of uPARþ /þ mice and uPAR/ mice at the age
of 18 weeks. Paraffin sections were stained with antibodies to a-SMA as described in the Materials and Methods section. (c) The number of a-SMA-positive cells
on the skin of uPARþ /þ mice and uPAR/ mice at the age of 18 weeks was determined at five randomly selected sites from different sections. The data
represent the mean±SEM. *Po0.01. (d) Type I collagen, type IV collagen, PAI-1, MMP-2, and MMP-9 gene expressions in the skin of uPARþ /þ mice and
uPAR/ mice at the age of 18 weeks were determined by RT-PCR. The histogram on the right panels shows quantitative representations of the expression
levels of the genes encoding type I collagen, type IV collagen, PAI-1, MMP-2, and MMP-9 obtained from densitometry analysis (n¼ 4). The data are expressed as
ratios of type I collagen, type IV collagen, PAI-1, MMP-2, and MMP-9 to GAPDH as percent increase relative to the skin of uPARþ /þ mice. The data represent
the mean±SEM. *Po0.01. (e) The MMP activity was analyzed in skin from uPARþ /þ mice and uPAR/ mice by zymography at the age of 18weeks. The
relative activity was quantified by scanning densitometry (n¼5). The data represent the mean±SEM. *Po0.01. Similar results were obtained with three
additional and different skin samples.
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proMMP-9, proMMP-10, and proMMP-13 (Nagase et al.,
2006). The activation of proMMP-2 involves hydrolysis by
MT1-MMP, yielding an intermediate that is activated by
plasmin (Nagase et al., 2006). In particular, both MMP-2 and
MMP-9 cleave type IV collagen and several other ECM
molecules (Nagase et al., 2006). Therefore, the production
and activity of MMP-2 and MMP-9 was investigated. These
results indicate that the absence of uPAR attenuates the
production and activity of MMP-2 and MMP-9. The activa-
tion of proMMP-9 may occur either through some plasmin-
dependent mechanisms or through plasmin-independent
mechanisms (Nagase et al., 2006). uPAR might be involved
in the production and activity of MMP-2 and MMP-9
regardless of the plasmin activity.
In conclusion, this study suggests that the absence of uPAR
regulates fibrosis-related gene expression and MMP activity
and also results in ECM deposition. As a result, the absence of
uPAR induces dermal fibrosis. These findings may hopefully
provide new insights into this field, which could eventually
lead to the development of new clinical therapies for the
prevention of fibrosis.
MATERIALS AND METHODS
Animals
Deficient mice were generated by homologous recombination using
embryonic stem cells as described previously (Dewerchin et al.,
1996). All experiments were performed in accordance with
institutional guidelines.
Reagents
All chemical substances were obtained from Sigma Chemical
(St Louis, MO).
Skin distension ability in mice
Skin distension ability in the skin of male and female uPARþ /þ mice
and uPAR/ mice at the age of 6, 10, and 18 weeks was measured
using a Cutometer SEM474 suction extensometer (n¼ 6). The section
was applied to a 2mm diameter area of the mouse’s skin surface.
The suction probe acted as a guard ring to preclude skin involvement
outside of the area measured. The probe was fitted with a spring that
ensured that it was applied to the skin at a constant pressure. Skin
elongation was measured by an optical method with an accuracy of
0.01mm using an infrared diode (Nishimori et al., 2001).
Scanning electron microscopy
The back skin of male uPARþ /þ mice and uPAR/ mice at the age
of 18 weeks was observed using an electron microscope S-3400N
(Hitachi High-Technologies, Tokyo, Japan) (n¼ 3). The samples
were examined with the electron microscope at 15 kV.
Measurement of dermal thickness
The dermal thickness (distance from the epidermal–dermal junction
to dermal–muscle junction) was measured in skin sections from male
uPARþ /þ mice and uPAR/ mice at the age of 18 weeks (n¼ 7).
Immunohistochemical staining of uPAR
The skin samples were obtained from male wild-type mice at the age
of 6, 10, and 18 weeks. The skin samples were excised by using a
punch biopsy instrument (Kai Medical, Gifu, Japan). Paraffin sections
were labeled with anti-uPAR (rabbit IgG, Santa Cruz Biotechnology,
Santa Cruz, CA) primary antibody and then secondarily labeled with
FITC-conjugated anti-rabbit IgG (Invitrogen, Carlsbad, CA). The signals
were then detected using a laser-scanning microscope. In each section,
uPAR-positive cells were counted in four randomly chosen fields.
Collagen content in skin (the sircol biochemical assay)
The collagen content was measured as previously described (Kanno
et al., 2007). The collagen content was assessed using Sirius red
staining. This approach was chosen because it accurately reflects the
collagen content assessed with hydroxyproline assay and allows
areas of localized collagen accumulation to be specifically
evaluated. In these assays, sections of skin are stained with Sirius
red as described by Junqueira et al. (1979). After deparaffinization,
the skin sections are treated in 0.2% phosphomolybdic acid for
5minutes. Next, the skin section was stained in 0.1% Sirius red for
90minutes and in 0.01 N HCl for 2minutes. The red stain was then
detected using a laser-scanning microscope. In each section, Sirius
red-positive area was measured in five randomly chosen fields and
expressed as a percent of the observed in uPARþ /þ mice.
Detection of myofibroblasts
Paraffin-embedded tissue sections from the skin were used to
quantify the number of myofibroblasts by staining for a-SMA. After
deparaffinization, the skin sections were immunostained with a mAb
against a-SMA (clone 1A4; DakoCytomation, Glostrup, Denmark),
according to the manufacturer’s instructions, using the Dako
Autostainer Universal Staining System. Thereafter, the sections
were secondarily labeled with FITC-conjugated anti-rabbit IgG
(Invitrogen). The signals were then detected using a laser-scanning
microscope. In each section, a-SMA-positive cells were counted in
five randomly chosen fields.
RT-PCR
RT-PCR was performed as previously described (Kanno et al., 2006).
Skin samples were obtained from male uPARþ /þ and uPAR/ mice
at the age of 18 weeks. Total RNA was isolated from skin sample
using Isogen (Nippon Gene, Tokyo, Japan) and was reverse-
transcribed using M-MLV reverse transcriptase (Gibco BRL, Grand
Island, NY). The transcripts were amplified by PCR using Ex Taq
(TaKaRa, Kyoto, Japan). We used the following primer sequence: uPAR:
50-TCCACCGAATGGCTTCCAGTG-30 and 50-AGACAACACGAGG
GCACACAC-30; PAI-1: 50-AAAGGTATGATCAATGACTTACTGG-30
and 50-TCAAAGGGTGCAGCGATGAACATGC-30; MMP-2: 50-GAA
CACCATCGAGACCATGC-30 and 50-CATCATGGATTCGAGAA
AAG-30; MMP-9: 50-CAGCCGACTTTTGTGGTCTT-30 and 50-CGTG
GTGTTCGAATGGCCTT-30; type I collagen: 50-ATCCCCATGACT
GTCTATAG-30 and 50-CAAATAAGTGACCATCGCCA-30; type IV
collagen: 50-TACCTGCCACTACTTCGCTAAC-30 and 50-CGGATGG
TqGTGCTCTGGAAG-30; GAPDH: 50-TTCATTGACCTCAACTAC
ATG-30 and 50-GTGGCAGTGATGGCATGGAC-30. PCR amplifica-
tion of cDNA for 35 cycles was included at 94 1C denaturation
(60 seconds), 60 1C annealing (60 seconds), and 72 1C extension
(60 seconds). After PCR amplification, the amplified cDNAs
were further extended by additional incubation at 72 1C for
10minutes. An equal amount of each reaction was separated by
electrophoresis on 1% agarose gels and visualized with 10 mg/ml
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EtBr, and the signal strengths were quantified using a densitometric
program. After normalizing versus GAPDH intensity, percent
increase was determined for each gene. Each experiment was
repeated at least thrice.
Western blot analysis for uPAR
A western blot analysis was performed as previously described (Kanno
et al., 2008). Skin samples were obtained from male wild-type mice at
the age of 6, 10, and 18 weeks. Samples were homogenized with lysis
buffer (10mM Tris-HCl, pH 6.8, containing 1% SDS and 1% Triton
X-100) in the presence of proteases inhibitor cocktails (Sigma-Aldrich,
St Louis, MO). The lysates were centrifuged at 15,000 r.p.m. for
10minutes, and the resulting supernatants were collected. Proteins in
the supernatant were separated by electrophoresis on 10% SDS-
polyacrylamide gels and transferred to a nitrocellulose membrane. The
membrane was incubated at 4 1C overnight with a polyclonal antibody
to uPAR and then with peroxidase-conjugated antibody to rabbit IgG.
Immunoreactive proteins were detected using ECL detection reagents
(Amersham Pharmacia Biotech, Uppsala, Sweden). Each experiment
was repeated at least thrice.
MMP activity assay
The MMP activity assay was determined utilizing gelatin substrate
zymography. Skin samples were obtained from male uPARþ /þ mice
and uPAR/ mice at the age of 18 weeks (n¼ 5). Samples were
mixed with SDS-loading buffer and incubated for 30minutes at
37 1C. Samples and molecular weight markers were electrophoresed
in a 10% polyacrylamide gel containing 0.1% gelatin. The gel was
washed in 2.5% Triton X-100 to remove SDS and then incubated at
37 1C for 24–48 hours in 200mM NaCl containing 40mM Tris-HCl
and 10mM CaCl2 (pH 7.5). After staining with Coomassie Blue R-
250, gelatinases were identified as clear bands. The signal strengths
were quantified using a densitometric program.
Statistical analysis
All data are expressed as the mean±SEM. The statistical significance
of the effect of each treatment (Po0.01) was determined by the
analysis of variance (ANOVA) followed by the Student–Newman–-
Keuls test.
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